Elsevier

The Lancet

Volume 337, Issue 8748, 27 April 1991, Pages 1022-1024
The Lancet

EPIDEMIOLOGY
Prevalence and incidence of Becker muscular dystrophy

https://doi.org/10.1016/0140-6736(91)92671-NGet rights and content

Abstract

We measured the prevalence and incidence of Becker muscular dystrophy in the Northern Health Region of England, UK. Patients were identified from the records of the Regional Neurological Centre and Muscular Dystrophy Group laboratories, Newcastle upon Tyne, and by writing to local doctors. We used cDNA probes and/or dystrophin immunolabelling of muscle-biopsy samples to prove the diagnosis of all cases. Results were compared with the known prevalence and incidence of Duchenne muscular dystrophy. 73 patients alive and resident in the Northern Health Region were identified, giving a prevalence rate of 2·38/100 000. This compares with a prevalence of Duchenne muscular dystrophy of 2·48/100 000. The cumulative birth incidence of Becker muscular dystrophy (at least 1 in 18 450 male live births) was about one third that of Duchenne muscular dystrophy (1 in 5618 male live births), suggesting that the disorder is more common than previously thought.

References (18)

There are more references available in the full text version of this article.

Cited by (150)

  • Other omics approaches to the study of rare diseases

    2021, Genomics of Rare Diseases: Understanding Disease Genetics Using Genomic Approaches
View all citing articles on Scopus
View full text